Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology OP-4 Current status of Liver transplantation in Latin America: The Latin-America...
Journal Information
Vol. 24. Issue S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(September 2021)
Share
Share
Download PDF
More article options
Vol. 24. Issue S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(September 2021)
Open Access
OP-4 Current status of Liver transplantation in Latin America: The Latin-American ALEH special interest group, international Survey 2020
Visits
885
Rodrigo Zapata1, Graciela Castro2, Josefina Pages3, Fernando Cairo4, Oscar Imventarza5, Alejandra Villamil6, Paulo Bittencourt7, Leonardo Schiavon8, Alfeu de Medeiros Fleck Jr9, Ricardo Villarroel10, Oscar Varas11, Juan Carlos Restrepo12, Adriana Varon13, Daniela Hernandez14, Pablo Coste15, Marcia Samada16, Antonio Enamorado17, Chong Ricardo18, Byron Abad19, Alvaro Urzúa20..., Rodrigo Wolff21, Mario Uribe22, Reginali Gorrea23, Edgard Aguilera24, Eira Cerda25, Sergio Lopez26, Marcos Girala27, Martin Padilla28, Marlene Pérez29, Victoria Mainardi30, Solange Gerona31Ver más
1 Coordinator, ALEH Liver Transplant SIG. Unidad de Trasplante, Clínica Alemana/Facultad de Medicina, Universidad del Desarrollo, Santiago, Chile
2 Co-Coordinator, ALEH Liver Transplant SIG. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran y Hospital Medica Sur, Ciudad de México, México
3 Liver Transplant Unit, Hospital Universitario Austral, Universidad de Buenos Aires, Buenos Aires, Argentina
4 Liver Transplant Unit, Hospital el Cruce, Hospital Británico, Buenos Aires, Argentina
5 Liver Transplant Unit, Hospital Argerich, Hospital Garrahan, Stalyc Representative, Buenos Aires, Argentina
6 Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
7 Liver Unit, Hospital Portugues de Salvador, Bahi, Brazil
8 Universidad Federal de Santa Catarin, Florianopolis, Santa Catarina, Brazil
9 Liver Transplant Unit, Hospital Moinhos de Vento, Irmandade de Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil
10 Hospital San Juan de Dios, Santa Cruz de la Sierra, Bolivia
11 Centro de Enfermedades Digestivas Varas Castrillo, Tarija, Bolivia
12 Liver Transplant Unit, Hospital Pablo Tobon Uribe, Medellín, Colombia
13 Liver Unit, Fundación Cardioinfantil, Bogota, Colombia
14 Hospital México, La Oruca, San José, Costa Rica
15 Hospital Rafael Ángel Calderón Guardia, San José, Costa Rica
16 Centro de Investigaciones Medico-Quirúrgicas, La Habana, Cuba
17 Programa de Trasplantes, La Habana, Cuba
18 Liver Transplant Unit, Hospital de Especialidades Carlos Andrade Marin, Quito, Ecuador
19 Transplant Coordinator, Hospital de Especialidades Arlos Andrade Marin, Quito, Ecuador
20 Liver Transplant Unit, Hospital Clínico, Universidad de Chile y Clínica Santa María, Santiago, Chile
21 Liver Transplant Unit, P. Universidad Católica de Chile, Santiago, Chile
22 Liver Transplant Unit, Hospital Salvador, Hospital Calvo Mackena y Clínica Las Condes, Stalyc Representative, Santiago, Chile
23 Hospital San Juan de Dios, Ciudad de Guatemala, Guatemala
24 Hospital Clínica Viera, Tegucigalpa, Honduras
25 Unidad de Trasplante Hepático, Hospital Central Militar, Ciudad de México, México
26 Hospital Escuale Dr. Roberto Calderon, Managua, Nicaragua
27 Universidad Nacional de Asunción, Asunción, Paraguay
28 Department of Transplantation, Hospital Nacional Guillermo Almenara y Universidad Nacional Mayor de San Marcos, Lima, Perú
29 Liver Transplant Unit, Hospital General de la Plaza de la Salud, Santo Domingo, República Dominicana
30 Liver Transplant Unit, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay
31 Liver Transplant Unit, Hospital de Clínicas y Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay
Ver más
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Download PDF
Statistics
Tables (1)
Table 1. Summary of current LT practices in LA (LT: Liver Transplantation; DDLT: Deceased donor LT; LDLT: Living donor LT; Rates: per million population; GDP: Gross domestic product; LOS: Length of stay of hospitalization for LT; Pop: Population; pp: per capita; Mill: Millions; Dom. Rep.: Dominican Republic; USD: US Dollars; Hosp: Hospitalization)
Special issue
This article is part of special issue:
Vol. 24. Issue S1

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

More info
Introduction

Latin America (LA), is a geographical region with 20 countries homing 652 million people (10% world population), with a huge cultural, economic and developmental diversity. The ALEH (Asociación Latinamericana para el Estudio del Hígado) has driven the formation of a special interest groups (SIGs) to enhance the collaboration of health care professionals with common specialized interests in the field of hepatology.

Aims To increase knowledge of the current situation of liver transplantation (LT) in LA, and share experiences between countries.

Methods

During 2020, LA countries, were invited to nominate representatives to this SIG and also from the STALYC. Online ZOOM meetings were arranged to discuss a survey with more than 70 questions in relation to LT. A database with all the information was built in an excel file.

Results

15 out of 20 countries completed the questionnaire by Jan/2021, representing the situation of 569 million inhabitants. The mean GDP (gross domestic product) per capita in 2019, was 14,573 USD, and the mean health expenditure was 6,3% of the GDP (1,6%-10,4%). Despite the lack of resources in LA, LT started early (Brazil: 1968) and currently 3,837 a total of LT are performed each year, with 12,5% with living donors (n=483). Over the last 50 years, 34,029 total LT have been performed in LA.

13 out of 15 countries (84%) perform DDLT and only 7 countries (46%) also LDLT. The allocation system is based in the MELD/MELD-Na system. The mean waiting time for cirrhotic patients is 276 days (with a waiting list mortality of 10-50%). The mean overall survival at 1 and 5 years after LT is 79,3% and 71,9%, which is similar to developed countries.

Conclusions

Access to LT in the region is very heterogeneous, with limited centers and resources to perform LT. Financial, human and material issues, a legal framework favoring organ donation and the procurement structure constitutes a major challenge to improve LT in LA. The collaborative sharing of experiences between countries and centers, may favor the development of guidelines for the region stimulating government initiatives to improve LT access, favoring justice and equity for patients with advanced liver diseases.

Full text is only aviable in PDF
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos